BRAF and colorectal cancer: For example, a study from 201327 found that aspirin use (which has consistently been shown to decrease colorectal cancer risk28) seemed to specifically lower the risk of BRAF‐nonmutated colorectal cancer but not BRAF‐mutated colorectal cancer.